Papular, Nodular Eruptions Frequent With Anti-PD1/PD-L1 Therapy

Share this content:
Many patients with advanced cancer receiving anti-PD-1 or anti-PD-L1 treatment have papular and nodular eruptions with scale with lichenoid features.
Many patients with advanced cancer receiving anti-PD-1 or anti-PD-L1 treatment have papular and nodular eruptions with scale with lichenoid features.

Many patients with advanced cancer receiving anti-programmed cell death 1 (PD-1) or anti-programmed cell death ligand 1 (PD-L1) treatment have papular and nodular eruptions with scale with lichenoid features, according to a study published in JAMA Dermatology.1

Researchers enrolled and observed 13 men and 7 women with advanced cancer who were referred to Yale-New Haven Hospital in Connecticut after developing cutaneous adverse effects while receiving an anti-PD-1 or PD-L1 therapy. The patients were receiving the therapies either alone or in combination with another agent.

It was found that 16 of the observed patients (80%) had a clinical morphology that consisted of erythematous papules with scale in a variety of distributions. Among 17 patients who had available biopsies, 16 showed features of lichenoid interface dermatitis.

RELATED: Radio/Immunotherapy Combination May Be Effective on Specific Tumor Types

In total, 18 patients were treated with topical corticosteroids, and only 1 patient required discontinuation of anti-PD-1/PD-L1 therapy. Sixteen patients were found to be concurrently taking medications that have been previously reported to cause lichenoid drug eruptions.

Reference

  1. Shi VJ, Rodic N, Gettinger S, et al. Clinical and histologic features of lichenoid mucocutaneous eruptions due to anti–programmed cell death 1 and anti–programmed cell death ligand 1 immunotherapy. JAMA Dermatol. doi:10.1001/jamadermatol.2016.2226 [Epub ahead of print]

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs